Jean Hurteau

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

The Lancet Oncology · 2014 · 479 citations

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy

International journal of radiation oncology · 2006 · 263 citations